Background The stability of creatinine in whole blood is unclear: it is not known if analysis of creatinine in samples with delayed separation could lead to misclassification of chronic kidney disease (CKD) using estimated glomerular filtration rate (eGFR).
Introduction
Most UK laboratories are following Department of Health advice 1 and reporting estimated glomerular ¢ltration rate (eGFR) on creatinine requests from general practice. These samples in particular can be subject to prolonged transit times, and observations in our laboratory have led to suspicion that delay before centrifugation can lead to falsely increased creatinine concentrations. This has potential implications for eGFR and chronic kidney disease (CKD) classi¢cation.
While various studies have indicated stability of creatinine in separated serum, 2,3 stability in whole blood is not clearly de¢ned. 3, 4, 5 A World Health Organisation document 3 states that creatinine is stable in whole blood for 2--3 days, but another report quotes changes of creatinine in stored blood of approximately 6% per day. 4 This study aimed to investigate the stability of measured creatinine in stored blood using some of the common analytical methods in current widespread use.
Methods

Impact of delay in centrifugation on creatinine concentration
Five healthy non-fasting volunteers (2 male, 3 female, aged 27--64 y) participated in the study for which ethical approval was given. From each subject a set of six 5 mL blood samples were collected into serum separator vacutainers (SST P Advance, BD UK Ltd, Oxford, UK). Samples were kept at room temperature (211C) and at de¢ned time points after collection (15 min, 4 h, 8 h,14 h, 24 h,31h) one from each volunteer was centrifuged (1600 g for 5 min). After centrifugation samples were stored at 41C until analysis. Samples analysed at other laboratories were aliquoted (immediately after analysis by our own laboratory method) and sent by ¢rst class post and refrigerated until analysis.
All samples were analysed for creatinine in singleton in a batch using ¢ve di¡erent methods, namely; Beckman DXC 800, CRE3 kinetic Ja¡e (Beckman Coulter UK Ltd, High Wycombe, UK), Bayer Advia kinetic Ja¡e (Bayer Healthcare, Berks, UK), Roche Modular P-800 kinetic Ja¡e and Roche Modular P-800 Creatinine Plus enzymatic assay (Roche Diagnostics Ltd, Lewes, East Sussex, UK) and Vitros 5.1 enzymatic creatinine (Ortho-Clinical Diagnostics Ltd, High Wycombe, UK). For all methods the between-batch coe⁄cient of variation (CV %) at a level of 100 umol/L was less than 2%.
Impact of delayed centrifugation on eGFR in patient samples
Twenty-four patients where sample time was stated (10 female, 14 male) and for whom two vacutainers were received by the laboratory were used. Analysis was performed by Ja¡e methodology on a Beckman DXC 800 analyser. One of the pair was promptly analysed (within 1h) after receipt in the laboratory and the second specimen was left at room temperature (211C) and analysed after centrifugation up to 28 h later. The eGFR on each sample was determined and the di¡erences between each sample pair were compared.
Statistical analyses were performed using paired t-tests (Analyze-it for Microsoft Excel, Microsoft corporation,Washington USA).
Results
A 24 h delay in centrifugation of whole blood resulted in signi¢cant increases in measured creatinine when assayed by each of the individual Ja¡e methods investigated (Po0. 025). For each Ja¡e method, the di¡erence in paired sample creatinine results between 0 h and 24 h expressed as mean di¡erence (95% con¢dence interval) are as follows: Beckman DXC --19.7 umol/L (7.3--32.2), Roche Modular --10.2 umol/L (3.6--16.8), Bayer Advia --6.2 umol/L (1.5--11.0). The enzymatic methods on both the Roche Modular and Vitros 5.1analysers showed no signi¢cant di¡erence (P40.2) in creatinine concentration over 31h (Figure 1) .
The most marked e¡ect was observed with our own laboratory method (Beckman DXC 800), with a maximum percentage change in creatinine after 31h of 67% ( Figure 2 ). Measured creatinine was stable when whole blood was centrifuged within 14 h of collection, on all of the platforms and subjects studied (Figures 1  and 2) .
The 24 pairs of patient samples also showed a time dependant increase in measured creatinine using the Beckman DXC 800 Ja¡e method (Figure 3 ). There was no signi¢cant di¡erence in creatinine concentration Figure 1 Mean serum creatinine concentration from five subjects, measured on various platforms (as indicated) after delayed centrifugation of whole blood before 10 h delay in centrifugation (P ¼ 0.46). Signi¢cant and variable increases in measured creatinine were seen between 10--24 h delay in centrifugation (Po0.001). In 21 patients where the delay exceeded 10 h, a trend showing signi¢cantly decreased eGFR was evident, (P ¼ o0.001) resulting in a change in clas-si¢cation of CKD in four of these cases (Figure 4 ).
Discussion
The three kinetic Ja¡e methods used in this study have revealed an apparent instability of creatinine in whole blood within 24 h. This may have important implica-tions for eGFR and subsequent CKD staging when samples from primary care are delayed in transit. The consistency of results obtained by enzymatic methods within this time frame indicates that this apparent instability is not due to creatinine itself but to some interfering factor. The extent of this interference is variable between kinetic Ja¡e methods, with the Beckman DXC 800 having an average percentage increase of 42%. The e¡ect on the Bayer Advia and Roche Modular Ja¡e methods is somewhat lower, being 12% and 18% respectively after 31h.
There is variability not only between methods but also between individuals (Figure 2) , adding to the uncertainty surrounding the acceptance of delayed samples for creatinine measurement (Beckman DXC800, minimum change 23%, maximum change 67%). As expected, the ¢ndings using patient samples corroborate the data from the formal time course study and further demonstrates signi¢cant increases in measured creatinine between 10 h and 24 h. The observed change in creatinine impacts on eGFR: whilst some patients with a time delay of between10-28 h were mis-classi¢ed in this small study, the individual impact will depend on the proximity of the correct eGFR to a CKD staging threshold. 1 It is noted, however, that the routine reporting of eGFR is not universally recommended for CKD stages 1 and 2, 7 and that only one of the results in the patient group studied falsely transcended the eGFR threshold to CKD stage 3 (Figure 4) .
Interference in Ja¡e methods is well documented, and compounds such as ketones and pyruvate are known to give notable positive interference with the Beckman DXC 800 method. 6 The build up of such a metabolite in vitro could be responsible for the observed e¡ect. In general, Ja¡e methods are optimised to minimise interference from commonly encountered interfering substances and variations in the optimisation strategy between manufacturers may be responsible for the method dependent di¡erences seen.
In conclusion, delays in sample receipt can cause signi¢cant increases in measured creatinine by commonly used kinetic Ja¡e methods. This could lead to misclassi¢cation of CKD stage and possibly further unnecessary investigations. The use of enzymatic methods appears to provide more reliable CKD classi¢-cation in situations where specimens have taken time to reach the laboratory, for example samples from primary care where eGFR is widely applied. It is recommended that time dependant rejection criteria are established in laboratories measuring creatinine using Ja¡e methodology.
